Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study (METAFORE)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by Hospices Civils de Lyon. Recruitment status was Recruiting
Study NCT00843440
Information provided by Hospices Civils de Lyon
First Received on February 12, 2009.
Last Updated on October 12, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
